OGEN CIK: 1174940

Oragenics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
27.7
FY22:
14.3
FY23:
3.87
FY24:
1.47
FY25:
10.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.52
FY22:
0.47
FY23:
1.10
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
28.2
FY22:
14.8
FY23:
4.97
FY24:
1.47
FY25:
10.1

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.45
FY22:
1.60
FY23:
1.80
FY24:
1.68
FY25:
1.79
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.30
FY22:
0.15
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
26.5
FY22:
13.0
FY23:
3.17
FY24:
−0.21
FY25:
8.28
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
28.2
FY22:
14.8
FY23:
4.97
FY24:
1.47
FY25:
10.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data